TY  - CHAP
M1  - Book, Section
TI  - Cardiology Pharmacogenomics
A1  - Maxwell, Whitney D.
A2  - Lam, Jerika T.
A2  - Gutierrez, Mary A.
A2  - Shah, Samit
PY  - 2021
T2  - Pharmacogenomics: A Primer for Clinicians
AB  - LEARNING  OBJECTIVESIdentify  key  variants  associated  with  the  metabolism  and  clearance  of  antiplatelets,  beta  blockers,  statins,  and  vitamin  K  antagonists.Evaluate  literature  describing  the  clinical  impact  of  pharmacogenetic  variants  on  safety,  efficacy,  and  patient  outcomes  when  recommending  cardiology  pharmacotherapy.Review  Clinical  Pharmacogenetics  Implementation  Consortium  (CPIC)  guidelines  and  other  relevant  guidelines  for  pharmacogenetics-guided  dosing  recommendations.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1179509822
ER  -